已收录 272983 条政策
 政策提纲
  • 暂无提纲
Determination of Iron(II) in Pharmaceuticals Based on Its Catalytic Effect on the Bromate–Crystal violet Reaction by Spectrophotometric Detection
[摘要] A simple, selective, and sensitive kinetic spectrophotometric method with no need for removing iron(III) interference is proposed for determination of iron(II) in pharmaceutical and water samples. This method is based upon the catalytic effect of iron(II) on the sodium bromate–crystal violet system in acidic media. Decolourization of crystal violet was used to monitor the reaction spectrophotometrically at 630 nm. The variables affecting the reaction rate were investigated. Under the optimum conditions, iron(II) can be determined in the range of 0.10 – 3.0 μg ml-1 with a 3σ detection limit of 0.025 μg ml-1. The relative standard deviations for ten replicate determinations of 0.50, 1.0, and 1.5µg ml-1 were 1.94%, 0.43%, and 0.28%, respectively. The influence of various foreign species was studied and it was found that without addition of a masking agent, Fe(III) did not interfere with the Fe(II) determination  up to 50-fold concentration of this ion.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 分析化学
[关键词] Ivabradine HCL;Pharmaceutical Dosage Form;RP-HPLC. Spectrophotometric;UV detector [时效性] 
   浏览次数:30      统一登录查看全文      激活码登录查看全文